American Heart Journal
Volume 152, Issue 3 , Pages 469.e1-469.e8 , September 2006

A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock

  • Daniel Burkhoff, MD, PhD

      Affiliations

    • Cardiovascular Research Foundation, Orangeburg, NY
    • ,
  • Howard Cohen, MD

      Affiliations

    • Lenox Hill Hospital, New York City, NY
    • ,
  • Corinna Brunckhorst, MD

      Affiliations

    • University Hospital Zurich, Zurich, Switzerland
    • Corresponding Author InformationReprint requests: Corinna Brunckhorst, MD, University Hospital Zurich, Zurich, Switzerland.
    • ,
  • William W. O'Neill, MD

      Affiliations

    • William Beaumont Hospital, Royal Oak, MI
    • ,
  • for the TandemHeart Investigators Group

Received 29 September 2005 ,Accepted 2 May 2006.

References 

  1. Korfer R, El Banayosy A, Arusoglu L, et al. Single-center experience with the thoratec ventricular assist device. J Thorac Cardiovasc Surg. 2000;119:596–600
  2. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625–634
  3. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190–192
  4. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162–1168
  5. Menon V, Fincke R. Cardiogenic shock: a summary of the randomized SHOCK trial. Congest Heart Fail. 2003;9:35–39
  6. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). Circulation. 1999;100:1016–1030
  7. Anderson RD, Ohman EM, Holmes DR, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I study. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol. 1997;30:708–715
  8. Hill JG, Bruhn PS, Cohen SE, et al. Emergent applications of cardiopulmonary support: a multiinstitutional experience. Ann Thorac Surg. 1992;54:699–704
  9. Scholz KH, Tebbe U, Chemnitius M, et al. Transfemoral placement of the left ventricular assist device “Hemopump” during mechanical resuscitation. Thorac Cardiovasc Surg. 1990;38:69–72
  10. Magovern JA, Sussman MJ, Goldstein AH, et al. Clinical results with the AB-180 left ventricular assist device. Ann Thorac Surg. 2001;71:S121–S124
  11. Meyns B, Dens J, Sergeant P, et al. Initial experiences with the Impella device in patients with cardiogenic shock—Impella support for cardiogenic shock. Thorac Cardiovasc Surg. 2003;51:312–317
  12. Thiele H, Lauer B, Hambrecht R, et al. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104:2917–2922
  13. Menon V, Hochman JS, Stebbins A, et al. Lack of progress in cardiogenic shock: lessons from the GUSTO trials. Eur Heart J. 2000;21:1928–1936
  14. Ohman EM, Hochman JS. Aortic counterpulsation in acute myocardial infarction: physiologically important but does the patient benefit?. Am Heart J. 2001;141:889–892
  15. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol. 2000;36:1123–1129
  16. Sanborn TA, Sleeper LA, Webb JG, et al. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol. 2003;42:1373–1379
  17. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998–3002
  18. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intraaortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–1283
  19. Sakamoto T, Suzuki A, Kazama S, et al. Effects of timing on ventriculoarterial coupling and mechanical efficiency during intraaortic balloon pumping. ASAIO J. 1995;41:M580–M583
  20. Kawaguchi O, Pae WE, Daily BB, et al. Ventriculoarterial coupling with intra-aortic balloon pump in acute ischemic heart failure. J Thorac Cardiovasc Surg. 1999;117:164–171

 This study was supported by CardiacAssist, Inc, Pittsburgh, PA

PII: S0002-8703(06)00552-7

doi: 10.1016/j.ahj.2006.05.031

American Heart Journal
Volume 152, Issue 3 , Pages 469.e1-469.e8 , September 2006

Article Tools

* Image Usage & Resolution